Derek K. Chu

1 month ago | bmj.com | Gordon Guyatt |Alfonso Iorio |Hans de Beer |Andrew Owen |Thomas Agoritsas |M Hassan Murad | +11 more

Research Methods & Reporting Core GRADE: Indirectness BMJ 2025; 389 doi: https://doi.org/10.1136/bmj-2024-083865 Cite this as: BMJ 2025;389:e083865 Gordon Guyatt, distinguished professor1 2 3, Alfonso Iorio, professor1 2, Hans De Beer, methodologist4, Andrew Owen, professor5, Thomas Agoritsas, professor1 3 6, M Hassan Murad, professor7, Ganesan Karthikeyan, professor, executive director8 9, Carlos Cuello, assistant professor1, Manya Prasad, associate professor10, Kevin Kim, methodologist1 11,...

Nov 4, 2024 | healio.com | Richard Gawel |Kristen Dowd |Bradley Chipps |Derek K. Chu

You've successfully added Asthma and Respiratory Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The meta-analysis included 27 unique randomized controlled trials and 50,496 patients.

Dec 29, 2023 | healio.com | Richard Gawel |Kristen Dowd |Jeffrey Cohen |Derek K. Chu

You've successfully added Allergy/Asthma: Skin Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Dec 19, 2023 | healio.com | Richard Gawel |Kristen Dowd |Jay Lieberman |Derek K. Chu

You've successfully added Allergy/Asthma: Anaphylaxis to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Based on response, patients may not need to visit the ED after using an epinephrine autoinjector.

Oct 13, 2023 | healio.com | Richard Gawel |Kristen Dowd |Derek K. Chu

You've successfully added Allergy/Asthma: Skin Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Pimecrolimus improved six of seven assessed outcomes. Upadacitinib was among the most effective but also most harmful.